Amal Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (NCT04046445) | Amal Therapeutics | 2019-07-22 |
Track Amal Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.